3/5
05:28 pm
bctx
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting [Canadian Business Journal (Canada)]
Low
Report
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting [Canadian Business Journal (Canada)]
3/5
04:04 pm
bctx
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Low
Report
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
2/18
05:30 pm
bctx
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
Neutral
Report
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
2/17
07:30 am
bctx
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Medium
Report
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
1/28
07:47 am
bctx
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]
Medium
Report
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]
1/28
07:30 am
bctx
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
Medium
Report
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
1/27
07:30 am
bctx
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Low
Report
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
1/15
04:05 pm
bctx
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
Medium
Report
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
2/26
02:41 pm
bctx
Form 25-NSE BriaCell Therapeutics Filed by: Nasdaq Stock Market LLC
Medium
Report
Form 25-NSE BriaCell Therapeutics Filed by: Nasdaq Stock Market LLC
2/20
04:01 pm
bctx
Form 8-K BriaCell Therapeutics For: Feb 18
Medium
Report
Form 8-K BriaCell Therapeutics For: Feb 18
2/12
04:00 pm
bctx
Form DEF 14A BriaCell Therapeutics For: Feb 12
Low
Report
Form DEF 14A BriaCell Therapeutics For: Feb 12
1/23
06:59 pm
bctx
Form SCHEDULE 13G BriaCell Therapeutics Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SCHEDULE 13G BriaCell Therapeutics Filed by: CITADEL ADVISORS LLC
1/15
04:16 pm
bctx
Form 8-K BriaCell Therapeutics For: Jan 13
Medium
Report
Form 8-K BriaCell Therapeutics For: Jan 13
1/14
04:16 pm
bctx
Form 424B4 BriaCell Therapeutics
Medium
Report
Form 424B4 BriaCell Therapeutics
1/14
06:04 am
bctx
Form EFFECT BriaCell Therapeutics
Medium
Report
Form EFFECT BriaCell Therapeutics
1/13
08:57 pm
bctx
Form S-1MEF BriaCell Therapeutics
High
Report
Form S-1MEF BriaCell Therapeutics
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register